Alan Skarbnik (@ASkarbnik), MD, director of the lymphoma and CLL program, Novant Health (Charlotte, NC), and Aaron Goodman (@AaronGoodman33), MD, hematologist, University of California San Diego, join the show for a long-awaited debate: treating double-hit lymphoma with R-CHOP vs dose-adjusted (DA)-EPOCH-R. The conversation gets testy when the trio describe ... Show More
Apr 21
Episode 276: Radiation Therapy for GI Cancer With Nina Sanford
Chadi sits down with Nina Sanford, MD, Chief of Gastrointestinal Radiation Oncology Service at UT Southwestern, to explore the evolving landscape of radiation therapy in upper and lower GI malignancies. They discuss how advances in systemic treatments are reshaping radiation stra ... Show More
36m 9s
Apr 14
Episode 275: PAVING the Path After Breast Cancer With Amy Comander
Chadi sits down with Amy Comander, MD, a breast cancer medical oncologist at Mass General Brigham Cancer Institute and author of “Paving Your Path Through Breast Cancer and Beyond,” to discuss how patients can take control of their health and quality of life after a breast cancer ... Show More
44m 5s
Apr 2023
Episode 234: Amar Kishan, MD, on Neoadjuvant or Adjuvant Radiotherapy for Prostate Cancer
<p>In the first part of our Hollywood tour, Amar Kishan, MD,
joins us to discuss his recent meta-analysis published in the Journal of
Clinical Oncology on the effects of concurrent adjuvant sequencing versus
neoadjuvant concurrent sequencing. Dr. Kishan also gives an overview of ... Show More
20m 35s
Dec 2021
Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced NSCLC
CHEST December 2021, Volume 160, Issue 6 Gerard A. Silvestri, MD, FCCP, and Adam H. Fox, MD, join CHEST Podcast Moderator Dominique Pepper, MD, to discuss the current knowledge and practice of pulmonologists regarding biomarker testing and targeted therapies in advanced non-small ... Show More
32m 8s
Jan 2024
What's New in Prostate Cancer, RCC, and mUC at GU24
<p>Drs. Neeraj Agarwal and Jeanny Aragon-Ching discuss several key abstracts to be presented at the 2024 ASCO GU Cancers Symposium, including sequencing versus upfront combination therapies for mCRPC in the BRCAAway study, updates on the CheckMate-9ER and CheckMate-214 trials in ... Show More
25m 10s
<p class="MsoNormal" style="text-align: justify;"><span class= "normaltextrun"><span style= "font-size: 11.0pt; line-height: 107%; font-family: 'Calibri',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-theme-font: major-fareast; mso-ansi-language: EN-US; mso-f ... Show More
